Income Statement (TTM)
Ardent Health, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
---|---|---|---|---|---|---|
Revenue | 5,532 | 5,634 | 5,706 | 5,966 | 6,024 | 6,199 |
Change (%) | 1.85 | 1.28 | 4.56 | 0.98 | 2.89 | |
% of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Cost Of Sales | 2,414 | 2,439 | 2,479 | 2,535 | 2,571 | 2,619 |
Change (%) | 1.07 | 1.63 | 2.25 | 1.43 | 1.85 | |
% of Revenue | 43.63 | 43.30 | 43.45 | 42.49 | 42.68 | 42.24 |
Gross Operating Profit | 3,118 | 3,194 | 3,227 | 3,431 | 3,453 | 3,580 |
Change (%) | 2.45 | 1.02 | 6.33 | 0.64 | 3.67 | |
% of Revenue | 56.37 | 56.70 | 56.55 | 57.51 | 57.32 | 57.76 |
SG&A | 2,267 | 2,311 | 2,344 | 2,383 | 2,404 | 2,444 |
Change (%) | 1.94 | 1.42 | 1.69 | 0.88 | 1.67 | |
% of Revenue | 40.98 | 41.02 | 41.07 | 39.94 | 39.91 | 39.43 |
R&D | ||||||
Change (%) | ||||||
% of Revenue | ||||||
OpEx | 5,287 | 5,365 | 5,431 | 5,560 | 5,627 | 5,766 |
Change (%) | 1.47 | 1.24 | 2.37 | 1.20 | 2.47 | |
% of Revenue | 95.58 | 95.23 | 95.19 | 93.20 | 93.41 | 93.03 |
Operating Income | 245 | 269 | 274 | 406 | 397 | 432 |
Change (%) | 9.94 | 2.00 | 47.88 | -2.15 | 8.89 | |
% of Revenue | 4.42 | 4.77 | 4.81 | 6.80 | 6.59 | 6.97 |
Interest Expense | -75 | -75 | -71 | -66 | -60 | -57 |
Change (%) | -0.71 | -5.89 | -6.98 | -7.75 | -5.67 | |
% of Revenue | -1.36 | -1.33 | -1.24 | -1.10 | -1.00 | -0.92 |
Net Income | 77 | 87 | 92 | 210 | 225 | 255 |
Change (%) | 12.62 | 6.34 | 128.67 | 6.82 | 13.43 | |
% of Revenue | 1.39 | 1.54 | 1.61 | 3.53 | 3.73 | 4.11 |
Source: Capital IQ